Krebs Biochemicals and Industries Q1FY22 loss increases to Rs. 9.42 Cr
Chemical

Krebs Biochemicals and Industries Q1FY22 loss increases to Rs. 9.42 Cr

The company reported total income of Rs.6.78 crores during the period ended June 30, 2021.

  • By ICN Bureau | July 31, 2021

Krebs Biochemicals and Industries has reported total income of Rs.6.78 crores during the period ended June 30, 2021 as compared to Rs.16.30 crores during the period ended March 31, 2021.

The company reported total income of Rs.11.61 crores during the period ended June 30, 2020.

The company has posted net loss of Rs.(9.42) crores for the period ended June 30, 2021 as against net lossof Rs.(6.98) crores for the period ended March 31, 2021.

It posted net loss of Rs.(6.72) crores for the period ended June 30, 2020.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization